武汉华康世纪洁净科技股份有限公司 独立董事提名人声明与承诺 提名人武汉华康世纪洁净科技股份有限公司董事会现就提名齐亮为武汉 华康世纪洁净科技股份有限公司第三届董事会独立董事候选人发表公开声明。 被提名人已书面同意作为武汉华康世纪洁净科技股份有限公司第三届董事会 独立董事候选人（参见该独立董事候选人声明）。本次提名是在充分了解被提 名人职业、学历、职称、详细的工作经历、全部兼职、有无重大失信等不良记 录等情况后作出的，本提名人认为被提名人符合相关法律、行政法规、部门规 章、规范性文件和深圳证券交易所业务规则对独立董事候选人任职资格及独立 性的要求，具体声明并承诺如下事项： 一、被提名人已经通过武汉华康世纪洁净科技股份有限公司第二届董事会 提名委员会资格审查，提名人与被提名人不存在利害关系或者其他可能影响独 立履职情形的密切关系。 ☑ 是 □ 否 如否，请详细说明：______________________________ 二、被提名人不存在《中华人民共和国公司法》第一百七十八条等规定不 得担任公司董事的情形。 ☑ 是 □ 否 如否，请详细说明：______________________________ 三、 ...

3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所创 业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号—创业板上市公 司规范运作》等法律、行政法规、部门规章、规范性文件及《公司章程》的有关规定。 4、会议时间： （1）现场会议时间：2025 年 11 月 27 日 14:30 | 证券代码：301235 | 证券简称：华康洁净 | 公告编号：2025-131 | | --- | --- | --- | | 转债代码：123251 | 转债简称：华医转债 | | 武汉华康世纪洁净科技股份有限公司 关于召开 2025 年第四次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、召开会议的基本情况 1、股东会届次：2025 年第四次临时股东会 2、股东会的召集人：董事会 （1）在股权登记日持有公司已发行有表决权股份的股东或其代理人；于股权登 记日下午收市时在中国结算深圳分公司登记在册的公司全体已发行有表决权股份的股 东均有权出席股东会，并可以以书面形式委托代理人出席会议和参加表决，该股东代 理人不必是本公司股东。 ...

国浩律师（武汉）事务所 关 于 武汉华康世纪洁净科技股份有限公司 2025 年第三次临时股东大会 国浩律师（武汉）事务所 关于武汉华康世纪洁净科技股份有限公司 2025 年第三次临时股东大会的 法律意见书 2025 鄂国浩法意 GHWH196 号 的 法律意见书 湖北省武汉市洪山区欢乐大道一号宏泰大厦 21 楼 邮编：430077 The 21st floor, Hongtai Building, No. 1 Huanle Avenue, Hongshan District, Wuhan city, Hubei Province, China 电话/Tel: (+86)(027) 87301319 传真/Fax: (+86)(027) 87265677 网址/Website:http://www.grandall.com.cn 2025 年 11 月 国浩律师（武汉）事务所 法律意见书 一、本次股东大会的召集、召开程序 致：武汉华康世纪洁净科技股份有限公司 国浩律师（武汉）事务所（以下简称"本所"）担任武汉华康世纪洁净科技 股份有限公司（以下简称"公司"）之常年法律顾问，根据《中华人民共和国公 司法》（以下简 ...

| 证券代码：301235 | 证券简称：华康洁净 | 公告编号：2025-127 | | --- | --- | --- | | 转债代码：123251 | 转债简称：华医转债 | | 武汉华康世纪洁净科技股份有限公司 1、 召开时间：2025 年 11 月 10 日（星期一）14:30 2、 召开地点：湖北省武汉市东湖新技术开发区高新大道 718 号 3 栋 29 楼 公司会议室 3、 召开方式：现场结合网络 4、 召集人：董事会 2025 年第三次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示 1、 本次股东大会不存在否决议案的情形。 2、 本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开及出席情况 （一）会议召开情况 5、 主持人：经公司过半数董事推选，本次股东大会由公司董事、总经理 谢新强先生主持； 6、 本次会议的召集、召开符合《中华人民共和国公司法》《上市公司股 东会规则》《深圳证券交易所创业板股票上市规则》等有关法律、行政法规、部 门规章、规范性文件和《武汉华康世纪洁净科技股份有限公司章程》的有关规 ...

Core Viewpoint - The company has been facing challenges with accounts receivable, leading to significant provisions for credit impairment losses, which have impacted net profits despite the expectation of eventual recovery of these amounts [2]. Group 1: Financial Performance - The company reported a provision of 120 million yuan for credit impairment losses in the previous year, 16.71 million yuan in the current interim report, and 28 million yuan in the third quarter, which collectively account for more than half of the profits [2]. - The net credit impairment loss reflects the net amount of bad debt provisions made and reversed during the period, indicating a continuous rolling process of provisions and reversals [2]. Group 2: Accounts Receivable Management - The company emphasizes that the provisions are primarily due to long repayment cycles from large and medium-sized public hospitals, rather than deteriorating creditworthiness of clients [2]. - The management is actively focusing on accounts receivable management and is committed to improving collection efforts [2]. Group 3: Accounting Practices - The company follows the prudence principle as per the Accounting Standards for Enterprises, leading to significant new provisions for bad debts in line with the growth of accounts receivable [2]. - The actual amount of bad debt provisions reversed during the period was lower than the new provisions made, resulting in a net provision status reflected in the profit and loss statement [2].

Core Viewpoint - Huakang Clean achieved significant revenue growth and profitability in the first nine months of 2025, indicating strong business performance in the medical purification sector [2]. Group 1: Financial Performance - For the period from January to September 2025, Huakang Clean reported operating revenue of 1.431 billion yuan, representing a year-on-year increase of 32.59% [2]. - The net profit attributable to the parent company reached 61.1567 million yuan, showing a substantial year-on-year growth of 211.46% [2]. Group 2: Shareholder and Market Activity - As of October 31, 2025, the number of Huakang Clean's shareholders increased to 10,600, up by 2.43% from the previous period [2]. - The average number of circulating shares per shareholder decreased by 2.37% to 6,845 shares [2]. - On November 6, 2025, Huakang Clean's stock price rose by 0.40%, with a trading volume of 55.2064 million yuan [1]. Group 3: Financing and Margin Trading - On November 6, 2025, Huakang Clean had a financing buy-in amount of 6.5431 million yuan, while the financing repayment was 9.0856 million yuan, resulting in a net financing buy of -2.5425 million yuan [1]. - The total margin trading balance for Huakang Clean reached 98.7520 million yuan, accounting for 3.05% of its market capitalization, which is above the 90th percentile of the past year [1]. - There were no shares sold or repaid in the securities lending market on November 6, 2025, with the securities lending balance also at zero, indicating a high level of inactivity in this area [1]. Group 4: Dividend Distribution - Huakang Clean has distributed a total of 40.0214 million yuan in dividends since its A-share listing, with 29.4614 million yuan distributed over the past three years [3]. Group 5: Institutional Holdings - As of September 30, 2025, new institutional shareholders include Fortune Optimized Enhanced Bond A/B and Fortune Jiuli Steady Configuration Mixed A, which are now among the top ten circulating shareholders [3].

Core Viewpoint - Huakang Clean experienced a stock price decline of 2.16% on November 4, with a current price of 29.96 CNY per share and a market capitalization of 3.229 billion CNY [1] Financial Performance - For the period from January to September 2025, Huakang Clean achieved a revenue of 1.431 billion CNY, representing a year-on-year growth of 32.59% [2] - The net profit attributable to the parent company was 61.1567 million CNY, showing a significant year-on-year increase of 211.46% [2] Shareholder Information - As of October 20, 2025, the number of Huakang Clean's shareholders decreased by 1.61% to 10,400, while the average circulating shares per person increased by 1.64% to 7,011 shares [2] - The company has cumulatively distributed dividends of 40.0214 million CNY since its A-share listing, with 29.4614 million CNY distributed over the past three years [3] Stock Market Activity - Huakang Clean's stock has seen a year-to-date increase of 48.60%, but has declined by 3.48% over the last five trading days and 10.73% over the last 20 days [1] - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent appearance on July 31 [1] Business Overview - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of Huakang Clean includes 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other sources [1] - The company operates within the pharmaceutical and biological industry, specifically in the medical device sector, and is involved in concepts such as medical waste treatment, assisted reproduction, medical devices, smart healthcare, and artificial intelligence [1]

Core Viewpoint - Huakang Clean is a national high-tech enterprise specializing in cleanroom integration services, with a focus on medical purification systems, laboratory, and electronic clean areas, showing strong growth potential in its business segments [1][6]. Group 1: Company Overview - Huakang Clean was established on November 12, 2008, and was listed on the Shenzhen Stock Exchange on January 28, 2022, with its registered and operational base in Wuhan, Hubei Province [1]. - The company has a full industry chain capability encompassing design, construction, procurement, and after-sales service [1]. Group 2: Financial Performance - In Q3 2025, Huakang Clean achieved a revenue of 1.431 billion yuan, ranking 13th in the industry, below the top competitor Mindray Medical at 25.834 billion yuan [2]. - The net profit for the same period was 62.9392 million yuan, ranking 23rd in the industry, also below Mindray Medical's 7.814 billion yuan [2]. - The company's gross profit margin was 32.78%, lower than the industry average of 48.67% [3]. Group 3: Debt and Profitability - As of Q3 2025, Huakang Clean's debt-to-asset ratio was 54.02%, higher than the industry average of 27.21% [3]. - The company’s gross profit margin decreased from 35.05% in the previous year to 32.78% [3]. Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders increased by 7.11% to 10,700 [5]. - The average number of circulating A-shares held per shareholder decreased by 6.63% to 6,789.63 [5]. Group 5: Growth Potential - Huakang Clean has seen a significant increase in its order backlog, growing from 1.727 billion yuan in 2022 to 3.706 billion yuan in H1 2025 [6]. - The company is expanding into the electronic clean area, having established an electronic division in 2024 and winning multiple projects [6]. - Revenue projections for 2025-2027 are estimated at 2.542 billion yuan, 3.547 billion yuan, and 4.598 billion yuan, with net profits of 153 million yuan, 225 million yuan, and 332 million yuan respectively [6].

Key Highlights - Cambridge Technology currently does not produce chips containing CPO technology [1] - TCL Technology plans to invest 29.5 billion yuan in the construction of an 8.6-generation printed OLED production line [1] - Huakang Clean has won the bid for a "medical service construction project" [1] - Aotewei intends to acquire an 8.99% stake in its subsidiary Songci Electromechanical [1] - Shanghai Yizhong plans to repurchase shares worth 30 million to 35 million yuan [1] - Huaton Co. reported a pig sales revenue of 338 million yuan in August [1] - Tianma Technology has accumulated approximately 11,921.59 tons of eel out of the pool from January to August [1] - Mars Man's controlling shareholder plans to reduce holdings by no more than 2.94% [1] - Zhiwei Intelligent's actual controller plans to reduce holdings by no more than 2.9749% [1] - Donglin Investment plans to reduce holdings in Jin'an Guoji by no more than 2.878% [1] - Zhonglun New Materials intends to issue convertible bonds not exceeding 1.068 billion yuan [1] - Tuojing Technology plans to raise no more than 4.6 billion yuan through a private placement [1] Investment Projects - TCL Technology (000100.SZ) plans to invest 29.5 billion yuan in the construction of an 8.6-generation printed OLED production line [1] - Guangdong Jianke (301632.SZ) intends to invest in the implementation of the second phase of the Guangdong Jianke·Zhongshan Smart Gathering Project [1] - Nanfeng Co. (300004.SZ) plans to invest 50 million yuan in fixed assets for a 3D printing service project [1] Contracts and Acquisitions - Huakang Clean (301235.SZ) has won the bid for a "medical service construction project" [1] - Aotewei (688516.SH) intends to acquire an 8.99% stake in its subsidiary Songci Electromechanical [1] - Tianhua New Energy (300390.SZ) plans to acquire a 75% stake in Suzhou Tianhua Times [1] Share Buybacks - Chuangyuan Co. (300703.SZ) plans to repurchase 1.55% to 2.05% of its shares [2] - Yishitong (688733.SH) intends to repurchase shares worth 30 million to 55 million yuan [2] - Shanghai Yizhong (688091.SH) plans to repurchase shares worth 30 million to 35 million yuan [2] Operational Data - Huaton Co. (002840.SZ) reported a pig sales revenue of 338 million yuan in August [2] - Tianma Technology (603668.SH) has accumulated approximately 11,921.59 tons of eel out of the pool from January to August [2] Shareholding Changes - Sudda Co. (001277.SZ) plans to reduce holdings by no more than 3% [2] - Mars Man (300894.SZ) plans to reduce holdings by no more than 2.94% [2] - Zhiwei Intelligent (001339.SZ) plans to reduce holdings by no more than 2.9749% [2] - Jin'an Guoji (002636.SZ) plans to reduce holdings by no more than 2.878% [2] Other Financial Activities - China Merchants Shekou (001979.SZ) plans to issue preferred shares to raise no more than 8.2 billion yuan for real estate project construction [2] - Zhonglun New Materials (301565.SZ) intends to issue convertible bonds not exceeding 1.068 billion yuan [2] - Keli'er (002892.SZ) plans to raise no more than 1.006 billion yuan through a private placement [2] - Tuojing Technology (688072.SH) plans to raise no more than 4.6 billion yuan through a private placement [2]

Group 1 - The core viewpoint of the news is that Huakang Clean experienced a decline in stock price, dropping by 5.09% to 31.15 CNY per share, with a trading volume of 160 million CNY and a turnover rate of 6.99%, resulting in a total market capitalization of 3.357 billion CNY [1] - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of Huakang Clean includes: 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other sources [1] Group 2 - Among the top ten circulating shareholders of Huakang Clean, a fund under China Merchants Fund, specifically the China Merchants Quantitative Selected Stock A (001917), has newly entered the list in the third quarter, holding 470,000 shares, which accounts for 0.65% of the circulating shares [2] - The estimated floating loss for the fund today is approximately 784,800 CNY [2] - The China Merchants Quantitative Selected Stock A fund, established on March 15, 2016, has a latest scale of 3.663 billion CNY, with a year-to-date return of 43.95%, ranking 1030 out of 4218 in its category, and a one-year return of 48.62%, ranking 670 out of 3878 [2]